What is the requirement for continued IRB review of a study that was approved on February 15, 2019?

The requirement for continued IRB review of a study that was approved on February 15, 2019, is that the study needs to be re-reviewed on or before February 14, 2020. This aligns with the regulatory framework which typically requires that studies undergo a continuing review at least annually, or as specified by the IRB. Since the study received approval on February 15, 2019, the IRB must conduct a continuing review before the one-year mark, which is February 14, 2020. This ensures that the research continues to be ethical, compliant, and safe for all participants involved.

In this context, continuing review requirements aim to assess the ongoing risk to participants and to ensure that the research is still meeting ethical standards. While some options suggest annual or more frequent reviews, the exact timeframe points to the necessity for re-review by February 14, 2020, which reflects the one-year review cycle typical in human subjects research oversight.